MPS Code: 0644/2020
The goal of this learning activity is to provide pharmacists with an overview of allergic rhinitis (AR) and the role pharmacists play according to the next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines – a refined ARIA initiative that emphasises integrated patient-centred care. This module aims to provide pharmacists with an overview of the management of AR and the positioning of a single-dose azelastine– fluticasone propionate combination (MPAze-Flu) according to next-generation ARIA guidelines.
Who should participate:
Please read thoroughly & understand the module before attempting the assessment questions.
Terms & Conditions:
■ Participants must obtain a minimum score of 7/10 (70%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points
The modules/articles are best viewed with:
Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards-compliant browser may be required to view the modules.